Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × Sarcoidosis × Clear all

Phase

Status

Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 362 Carcinoma, Non-Small-Cell Lung 241 Prostatic Neoplasms 181 Neoplasms 173 Neoplasm Metastasis 166 Melanoma 141 Colorectal Neoplasms 133 Leukemia, Myeloid, Acute 130 Multiple Myeloma 128 Leukemia 113 Lung Neoplasms 111 Lymphoma 104 Pancreatic Neoplasms 99 Recurrence 94 Lymphoma, Non-Hodgkin 94 Leukemia, Lymphocytic, Chronic, B-Cell 93 Carcinoma, Renal Cell 93 Ovarian Neoplasms 90 Myelodysplastic Syndromes 82 Brain Neoplasms 81 Precursor Cell Lymphoblastic Leukemia-Lymphoma 75 Glioblastoma 75 Lymphoma, Follicular 73 Lymphoma, Large B-Cell, Diffuse 72 Carcinoma, Hepatocellular 70 Head and Neck Neoplasms 66 Squamous Cell Carcinoma of Head and Neck 65 Urinary Bladder Neoplasms 53 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 52 Hodgkin Disease 52

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00311246 2020-08-25

Trial of Adalimumab in Progressive Sarcoidosis

University of Chicago

Phase 2 Terminated

11 enrolled 8 charts

Sarcoidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡